Stella M. Savarimuthu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Stella M. Savarimuthu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Arisha Ramkillawan
Discipline of Anaesthesiology and Critical Care, Nelson R Mandela School of Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa
1 shared publication - Daniel Z. Hodson
David Geffen School of Medicine at the University of California (Los Angeles)
1 shared publication Douglas P.K. Wilson
1 shared publication- George L. Anesi
Division of Pulmonary, Allergy, and Critical Care, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
1 shared publication - Jonathan Invernizzi1 shared publication
- Laura R. Glick
Massachusetts General Hospital, Boston, MA, United States
1 shared publication
Latest Publications
- Open Access
- 30 October 2024
- Published by Elsevier in CHEST Critical Care
- Vol. 2 (4)
Operationalizing the New Global Definition of ARDS
- 30 October 2024
- Published by Elsevier in CHEST Critical Care
- Vol. 2 (4)
Open AccessOperationalizing the New Global Definition of ARDS
- Open Access
- 8 April 2022
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 6 (5) , ytac145
Cardiac tamponade as the initial presentation of autoimmune polyglandular syndrome Type 2: a case report
Background: Cardiac tamponade is a rare but serious manifestation of autoimmune polyglandular syndrome Type 2 (APS 2). Patients often present with symptoms of thyroid dysfunction and adrenal insufficiency, but the insidious onset of the disease may lead to delayed diagnosis, which can progress rapidly to haemodynamic instability requiring urgent intervention. Case summary: A 39-year-old previously healthy male was admitted with cardiac tamponade complicated by cardiac arrest requiring emergent pericardiocentesis. An extensive work up revealed primary adrenal insufficiency and Hashimoto’s thyroiditis. His positive autoantibodies to thyroid peroxidase and 21-hydroxylase combined with rapid improvement with initiation of corticosteroids and levothyroxine confirmed a diagnosis of APS 2. Discussion: Although this disease is often difficult to diagnose given its vague symptoms, it should be considered in the differential diagnosis for young patients presenting with pericardial effusion or cardiac tamponade of unknown origin. Early diagnosis and management are critical and often result in rapid improvement after appropriate treatment.
- 8 April 2022
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 6 (5) , ytac145
Open AccessCardiac tamponade as the initial presentation of autoimmune polyglandular syndrome Type 2: a case report
Background: Cardiac tamponade is a rare but serious manifestation of autoimmune polyglandular syndrome Type 2 (APS 2). Patients often present with symptoms of thyroid dysfunction and adrenal insufficiency, but the insidious onset of the disease may lead to delayed diagnosis, which can progress rapidly to haemodynamic instability requiring urgent intervention. Case summary: A 39-year-old previously healthy male was admitted with cardiac tamponade complicated by cardiac arrest requiring emergent pericardiocentesis. An extensive work up revealed primary adrenal insufficiency and Hashimoto’s thyroiditis. His positive autoantibodies to thyroid peroxidase and 21-hydroxylase combined with rapid improvement with initiation of corticosteroids and levothyroxine confirmed a diagnosis of APS 2. Discussion: Although this disease is often difficult to diagnose given its vague symptoms, it should be considered in the differential diagnosis for young patients presenting with pericardial effusion or cardiac tamponade of unknown origin. Early diagnosis and management are critical and often result in rapid improvement after appropriate treatment.